CME Group, a Zacks Rank #1 (Strong Buy), is the world’s leading and most diverse derivatives marketplace. CME Group operates ...

After back-to-back years of 20%-plus gains in 2023 and 2024, the S&P 500 is off to a sluggish start to 2025. Investors are dealing with a number of macroeconomic ...

Shares of CME Group CME have gained 10.7% year to date, outperforming the industry, the sector and the Zacks S&P 500 ...

CME Group (NASDAQ:CME – Free Report) had its target price increased by Barclays from $263.00 to $279.00 in a research note ...